Samalin Investment Counsel’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
CAM
WF
RG
LWCFA
Samalin Investment Counsel's IDXX Position: Q2 2026 in Review
Samalin Investment Counsel sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 431 shares — an estimated $242K sold.
Samalin Investment Counsel first reported a position in IDXX in Q4 2019 and held it in 23 quarters. The position peaked at $630K in Q4 2019. 485 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Samalin Investment Counsel reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- Samalin Investment Counsel sold 431 Idexx Laboratories shares in Q2 2026, an estimated $242K.
- Samalin Investment Counsel first reported a position in Idexx Laboratories in Q4 2019 and held it in 23 quarters.
- Samalin Investment Counsel's Idexx Laboratories position peaked at $630K in Q4 2019.
- 485 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.